×
About 107,818 results

ALLMedicine™ Squamous Cell Carcinoma Center

Research & Reviews  52,853 results

β-glucan therapy converts the inhibition of myeloid-derived suppressor cells in oral ca...
https://doi.org/10.1111/odi.13827
Oral Diseases; Lo YW, Lee AY et. al.

Mar 3rd, 2021 - The myeloid-derived suppressor cells (MDSCs) frequently have a high expansion in cancer patients. This research explored whether administration of β-glucan could increase anti-tumor immunity in oral squamous cell carcinoma (OSCC) patients. This st...

Exposure to chewing tobacco promotes primary oral squamous cell carcinoma and regional ...
https://doi.org/10.1111/iep.12386
International Journal of Experimental Pathology; Ray S, Saha D et. al.

Mar 3rd, 2021 - A high incidence of oral squamous cell carcinoma (OSCC) is observed in South-East Asian countries due to addictions such as chewing tobacco. Local invasion and distant metastases are primary causes of poor prognosis in OSCC. This study aimed to un...

Esophageal Cancer: An Updated Review.
https://doi.org/10.14423/SMJ.0000000000001226
Southern Medical Journal; DiSiena M, Perelman A et. al.

Mar 3rd, 2021 - The incidence of esophageal cancer (EC) is on the rise. With the distinct subtypes of adenocarcinoma and squamous cell carcinoma comes specific risk factors, and as a result, people of certain regions of the world can be more prone to a subtype. F...

ORAOV1-B Promotes OSCC Metastasis via the NF-κB-TNFα Loop.
https://doi.org/10.1177/0022034521996339
Journal of Dental Research; Luo X, Jiang Y et. al.

Mar 3rd, 2021 - Metastasis, a powerful prognostic indicator of oral squamous cell carcinoma (OSCC), is chiefly responsible for poor cancer outcomes. Despite an increasing number of studies examining the mechanisms underlying poor outcomes, the development of pote...

Genetic analysis of rapidly progressing esophageal squamous cell carcinoma: A case report.
https://doi.org/10.1097/MD.0000000000024462
Medicine Zhao S, Sun N et. al.

Mar 3rd, 2021 - Numerous investigations have been performed to explore candidate biomarker proteins in esophageal squamous cell carcinoma (ESCC) patients, which could predict the response to chemoradiotherapy (CRT). Here we report a patient with unresectable ESCC...

see more →

Guidelines  133 results

Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ES...
https://doi.org/10.1016/j.annonc.2020.07.011
Annals of Oncology : Official Journal of the European Soc... Machiels JP, René Leemans C et. al.

Nov 26th, 2020 - Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.|2020|Machiels JP,René Leemans C,Golusinski W,Grau C,Licitra L,|diagnosis,epidemiol...

Immunotherapy and Beyond: Treatment Options and Potential Markers in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
https://dailynews.ascopubs.org/do/10.1200/ADN.20.200227/full/

Jul 2nd, 2020 - Head and neck cancers account for approximately 4% of all cancers in the United States1 and are the eighth most common cancer affecting men in the United States.2 The diagnosis of recurrent or metastatic head and neck squamous cell carcinoma (R/M ...

Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline.
https://doi.org/10.1200/JCO.20.00866
Journal of Clinical Oncology : Official Journal of the Am... Shah MA, Kennedy EB et. al.

Jun 22nd, 2020 - To develop an evidence-based clinical practice guideline to assist in clinical decision making for patients with locally advanced esophageal cancer. ASCO convened an Expert Panel to conduct a systematic review of the more recently published litera...

FDA approves nivolumab for esophageal squamous cell carcinoma
https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-nivolumab-esophageal-squamous-cell-carcinoma
FDA

Jun 9th, 2020 - On June 10, 2020, the Food and Drug Administration approved nivolumab (OPDIVO, Bristol-Myers Squibb Co.) for patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC) after prior fluoropyrimidine- and p...

Key Efficacy End Points Upheld at 3 Years for Cemiplimab in CSCC
https://www.targetedonc.com/view/key-efficacy-end-points-upheld-at-3-years-for-cemiplimab-in-cscc

May 30th, 2020 - Three-year follow-up data from the phase 2 EMPOWER-CSCC-1 trial (NCT02760498) demonstrated a clinically meaningful survival and duration of response (DOR) improvement with cemiplimab-rwlc (Libtayo) in patients with advanced cutaneous squamous cell...

see more →

Drugs  31 results see all →

Clinicaltrials.gov  53,833 results

β-glucan therapy converts the inhibition of myeloid-derived suppressor cells in oral ca...
https://doi.org/10.1111/odi.13827
Oral Diseases; Lo YW, Lee AY et. al.

Mar 3rd, 2021 - The myeloid-derived suppressor cells (MDSCs) frequently have a high expansion in cancer patients. This research explored whether administration of β-glucan could increase anti-tumor immunity in oral squamous cell carcinoma (OSCC) patients. This st...

Exposure to chewing tobacco promotes primary oral squamous cell carcinoma and regional ...
https://doi.org/10.1111/iep.12386
International Journal of Experimental Pathology; Ray S, Saha D et. al.

Mar 3rd, 2021 - A high incidence of oral squamous cell carcinoma (OSCC) is observed in South-East Asian countries due to addictions such as chewing tobacco. Local invasion and distant metastases are primary causes of poor prognosis in OSCC. This study aimed to un...

Esophageal Cancer: An Updated Review.
https://doi.org/10.14423/SMJ.0000000000001226
Southern Medical Journal; DiSiena M, Perelman A et. al.

Mar 3rd, 2021 - The incidence of esophageal cancer (EC) is on the rise. With the distinct subtypes of adenocarcinoma and squamous cell carcinoma comes specific risk factors, and as a result, people of certain regions of the world can be more prone to a subtype. F...

ORAOV1-B Promotes OSCC Metastasis via the NF-κB-TNFα Loop.
https://doi.org/10.1177/0022034521996339
Journal of Dental Research; Luo X, Jiang Y et. al.

Mar 3rd, 2021 - Metastasis, a powerful prognostic indicator of oral squamous cell carcinoma (OSCC), is chiefly responsible for poor cancer outcomes. Despite an increasing number of studies examining the mechanisms underlying poor outcomes, the development of pote...

Genetic analysis of rapidly progressing esophageal squamous cell carcinoma: A case report.
https://doi.org/10.1097/MD.0000000000024462
Medicine Zhao S, Sun N et. al.

Mar 3rd, 2021 - Numerous investigations have been performed to explore candidate biomarker proteins in esophageal squamous cell carcinoma (ESCC) patients, which could predict the response to chemoradiotherapy (CRT). Here we report a patient with unresectable ESCC...

see more →

News  937 results

Fast Five Quiz: Non–Small Cell Lung Cancer Management
https://reference.medscape.com/viewarticle/923235

Feb 2nd, 2021 - Non–small cell lung cancer (NSCLC) accounts for the vast majority of all lung cancers and is a leading cause of death worldwide. Histologically, NSCLC is characterized as adenocarcinoma, squamous cell carcinoma, or large cell carcinoma. A complete...

Expert Offers Tips for Sorting Out Pink Lesions on Dermoscopy
https://www.medscape.com/viewarticle/945115

Feb 1st, 2021 - Even in the most experienced hands, dermoscopy poses a challenge when the usual pigment clues are lacking to help distinguish melanoma from amelanotic melanoma and pigmented basal cell carcinoma (BCC) from nonpigmented BCC. Dr Jennifer Stein "For ...

Gene Test Helps Inform Management of High-Risk SCC Patients
https://www.medscape.com/viewarticle/945044

Jan 31st, 2021 - Emerging data support the clinical validity and use of DecisionDx-SCC as a prognostic 40-gene expression profile test for patients with high-risk squamous cell carcinoma (SCC), according to Anna A. Bar, MD. "The incidence of SCC has been growing r...

SLN Biopsy for Oral Cancer? French Surgeons Say 'Oui'
https://www.medscape.com/viewarticle/940134

Nov 1st, 2020 - French investigators are suggesting that sentinel lymph node (SLN) biopsy should replace neck lymph node dissection as the new standard for detecting occult metastases in patients with T1-T2N0 oral and oropharyngeal squamous cell carcinoma. In a r...

Icotinib Plus Radiotherapy Ups Survival in Elderly With Esophageal Cancer
https://www.staging.medscape.com/viewarticle/939190

Oct 18th, 2020 - NEW YORK (Reuters Health) - Icotinib with concurrent radiotherapy (RT) boosts survival and may have other benefits compared to RT alone in elderly patients with unresectable esophageal squamous cell carcinoma, according to Chinese researchers. Dr....

see more →

Patient Education  31 results see all →